Effective therapeutic strategies for epithelioid sarcoma (EpS), a high‐grade soft tissue sarcoma characterized by loss of integrase interactor 1 (INI1), have not yet been developed. The gene discussed is SMARCB1; the disease is epithelioid sarcoma.